2 Citations (Scopus)


Beta-2- adrenergic agonists agonists are used in the treatment of reversible airway disease. β-blockers, due to their bronchoconstrictor effects, are supposed to be deleterious in such patients. In this review, we are putting forth some recent studies and meta analysis, which indicate that the chronic use of β-blockers in patients with reversible airway disease does not produce pulmonary impairment. Also, these drugs need not be withheld from patients with other diseases like hypertension, after weighing the risk: benefit ratio.

Original languageEnglish
Pages (from-to)414-417
Number of pages4
JournalJournal of Clinical and Diagnostic Research
Issue number2
Publication statusPublished - 06-05-2011

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'β -blockers in reactive airway disease'. Together they form a unique fingerprint.

  • Cite this